Marina Bellavia

Dr. Marina Bellavia studied at the Faculty of Medicine and Surgery at La Sapienza University of Rome, graduating in 2002 with a score of 110/110 cum laude. She began her postgraduate training at the Department of Gynecology and Obstetrics of the Policlinico Umberto I in Rome, particularly in the Endometriosis and Chronic Pain Center where she wrote her thesis on “Psychoimmunology of Endometriosis”. In 2005, she joined the Reproductive Medicine team of CHUV in Lausanne as an assistant and then as Head of Clinic. In 2007, she obtained her specialization in Gynecology and Obstetrics at the University of Bari with a score of 70/70 cum laude. In 2011, she obtained a specialization in Gynecological Endocrinology and Reproductive Medicine at the University of Lausanne.

Since 2013, Dr. Bellavia has been working at the Procrea Clinic in Lugano, and on April 1, 2021, she was appointed as the Medical Director.

Dr. Bellavia is a member of the Committee of the Swiss Society for Reproductive Medicine (SGRM) and FIVNAT. Her main areas of interest are assisted reproduction, with a particular focus on endometriosis, infertility surgery, male infertility, gynecological endocrinology, and menopause. Dr. Bellavia is also active in research at Next Fertility Procrea, collaborating on various research projects in the field of medically assisted procreation.

She is the author of numerous scientific publications:

Artificial Intelligence in Andrology: From Semen Analysis to Image Diagnostics.

Ghayda RA, Cannarella R, Calogero AE, Shah R, Rambhatla A, Zohdy W, Kavoussi P, Avidor-Reiss T, Boitrelle F, Mostafa T, Saleh R, Toprak T, Birowo P, Salvio G, Calik G, Kuroda S, Kaiyal RS, Ziouziou I, Crafa A, Phuoc NHV, Russo GI, Durairajanayagam D, Al-Hashimi M, Hamoda TAA, Pinggera GM, Adriansjah R, Maldonado Rosas I, Arafa M, Chung E, Atmoko W, Rocco L, Lin H, Huyghe E, Kothari P, Solorzano Vazquez JF, Dimitriadis F, Garrido N, Homa S, Falcone M, Sabbaghian M, Kandil H, Ko E, Martinez M, Nguyen Q, Harraz AM, Serefoglu EC, Karthikeyan VS, Tien DMB, Jindal S, Micic S, Bellavia M, Alali H, Gherabi N, Lewis S, Park HJ, Simopoulou M, Sallam H, Ramirez L, Colpi G, Agarwal A; Global Andrology Forum.World J Mens Health. 2024 Jan;42(1):39-61. doi: 10.5534/wjmh.230050.

Should patients be screened for chronic endometritis before assisted reproductive technology?

Cicinelli E, McQueen DB, Huepfel B, Vitagliano A, Moreno I, Simon C, Pirtea P, Scott RT Jr, Bellavia M, de Ziegler D.Fertil Steril. 2022 Oct;118(4):639-652. doi: 10.1016/j.fertnstert.2022.08.846.

Fertility preservation in cancer patients. Review of the French speaking part of Switzerland and recommendations for different situations.

Wunder D, Perey L; Réseau Romand Cancer et Fertilité; Achtari C, Ambrosetti A, Bellavia M, Delaloye JF, de Ziegler D, Gumy-Pause F, Helg C, Ketterer N, Petignat P, Primi MP, Rosselet-Christ A, Zaman K.Swiss Med Wkly. 2012 Oct 1;142:w13645. doi: 10.4414/smw.2012.13645. eCollection 2012.PMID: 23037142

Outlook: Roles of FSH and LH during the follicular phase: insight into natural cycle IVF.

de Ziegler D, Fraisse T, de Candolle G, Vulliemoz N, Bellavia M, Colamaria S.Reprod Biomed Online. 2007 Nov;15(5):507-13. doi: 10.1016/s1472-6483(10)60381-1.PMID:

Randomized controlled trial comparing highly purified (HP-hCG) and recombinant hCG (r-hCG) for triggering ovulation in ART.

Bellavia M, de Geyter C, Streuli I, Ibecheole V, Birkhäuser MH, Cometti BP, de Ziegler D.Gynecol Endocrinol. 2013 Feb;29(2):93-7. doi: 10.3109/09513590.2012.730577. Epub 2012 Nov 2.PMID: 23116325 Clinical Trial.

Poor reliability of vaginal and endocervical cultures for evaluating microbiology of endometrial cavity in women with chronic endometritis.

Cicinelli E, De Ziegler D, Nicoletti R, Tinelli R, Saliani N, Resta L, Bellavia M, De Vito D.Gynecol Obstet Invest. 2009;68(2):108-15. doi: 10.1159/000223819. Epub 2009 Jun 11.PMID: 19521097

Endometrial effects, bleeding control, and compliance with a new postmenopausal hormone therapy regimen based on transdermal estradiol gel and every-other-day vaginal progesterone in capsules: a 3-year pilot study.

Cicinelli E, de Ziegler D, Alfonso R, Nicoletti R, Bellavia M, Colafiglio G.Fertil Steril. 2005 Jun;83(6):1859-63. doi: 10.1016/j.fertnstert.2005.01.095.PMID: 15950667 Free article.

Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women.

Cicinelli E, Ranieri G, Maffei S, Colafiglio G, Ria R, Bellavia M, Schonauer MM.Fertil Steril. 2006 Oct;86(4):899-904. doi: 10.1016/j.fertnstert.2006.03.041. Epub 2006 Sep 11.PMID: 16963035 Free article. Clinical Trial.

Fertility and cancer: psychological support in young women who contemplate emergency assisted reproductive technologies (ART) prior to chemo- and/or radiation-therapy.

Besse D, Bellavia M, de Ziegler D, Wunder D.Swiss Med Wkly. 2010 Jul 16;140:w13075. doi: 10.4414/smw.2010.13075. eCollection 2010.PMID: 20652849 Free article.

Heterotopic cervical pregnancy: a case report.

Porpora MG, D’Elia C, Bellavia M, Pultrone DC, Cosmi EV.Acta Obstet Gynecol Scand. 2003 Nov;82(11):1058-9. doi: 10.1034/j.1600-0412.2003.00069.x.PMID: 14616283 Free article. No abstract available.

Preimplantation genetic diagnosis (PGD) for HLA typing: bases for setting up an open international collaboration when PGD is not available.

Bellavia M, Von Der Weid N, Peddes C, Jacquemont S, Liebaers I, Hohlfeld P, Wunder-Galié D, de Ziegler D.Fertil Steril. 2010 Aug;94(3):1129-31. doi: 10.1016/j.fertnstert.2009.11.007. Epub 2010 Jan 13.PMID: 20074727